Samarth Kulkarni

About

Dr. Samarth Kulkarni is the Chief Executive Officer of CRISPR Therapeutics. He has significant expertise in strategy and operations in biotech and a wide range of related cutting-edge therapeutic technologies. He joined CRISPR in 2015 in the early stages of the company as Chief Business Officer and then was appointed to President and Chief Business Officer before becoming CEO. Before joining our company, Sam was a Partner at McKinsey & Company, where he had a leading role in the Pharmaceutical and Medical products practice. While at McKinsey, he co-led the biotech practice, where he focused on strategy and operations, and led initiatives in areas such as personalized medicine and immunotherapy. Previously, Sam served as the Chairman of the Board of Directors of Casebia Therapeutics, a joint subsidiary formed by CRISPR Therapeutics and Bayer. Sam currently serves on the Board of Directors of two precision oncology companies, Black Diamond Therapeutics, and Repare Therapeutics. He receiv

Investment Focus

Location

US